An interventional study of Selective Peroneus longus excercise and Conventional physical therapy programme in Hallux Valgus, sponsored by Cairo University. Recruiting at 1 site in Egypt. Open to participants aged 18 Years to 60 Years. Per ClinicalTrials.gov, last updated 2024-08-12.
Sponsored by Cairo University · Not applicable, Interventional, and Treatment
Purpose of this study is to measure Change in Hallux valgus angle (HVA )as measured by kinovea software Change in pain as measured by numerical pain rating scale (NPRS) Change in function as measured by Foot function index (FFI )Egyptian version With the peroneus longus strengthening exercise versus the use of conventional physical therapy programme in cases of hallux valgus patients
157 studies on the registry are indexed under Hallux Valgus; 36 are open to participants now.
This study's planned enrollment of 60 is close to the median of 58 across 119 interventional studies indexed under Hallux Valgus.
Browse Hallux Valgus studies →Cairo University is the lead sponsor of 4,941 studies on the registry; 1,458 are open to participants now.
Of its 37 completed or terminated interventional studies of FDA-regulated products, 5 (14%) have results posted.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Group A will receive a weight bearing peroneus longus exercise with conventional physical therapy Programme
Other: Selective Peroneus longus excercise
Group B will receive a program consisting of 3 commonly used exercises in Hallux valgus
Other: Conventional physical therapy programme
Weight bearing peroneus longus exercise
Also known as: Band heel raises
* Passive abduction of the Hallux with traction * short foot exercise * toe spread outs
Hallux valgus angle HVA
Hallux valgus angle will be measures musing kinovea software
Time frame: Baseline , 6 weeks (after study completion )
Level of pain
Will be measured using numerical pain rating scale Where 0 represents no pain and 10 represents worst pain imaginable
Time frame: Baseline , 6 weeks after study completion
Foot function
Will be measured using Foot Function Index FFI Egyptian version Which is divided into 3 sub categories Pain 0 no pain , 10 worst pain Disability 0 least 10 worst Activity limitation 0 no limitation , 10 worst limitation For the total score, the minimum score is 0% (no pain or difficulty), and maximum score is 100% (worst pain and extreme difficulty requiring assistance).
Time frame: Baseline , 6 weeks after study completion
Start is estimated for Sep 2024; primary completion for Nov 2024, 2 months later.
Of 51 non-industry interventional studies with no phase under Hallux Valgus, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 55. This study's planned 2 months is below that.
Counting every sponsor, half of 56 studies reached it within 26 months; a quarter within 11 and three quarters within 55.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.